News
The Food and Drug Administration approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent ...
The recalls have been classified as Class II, where the probability of serious adverse health consequences is remote.
With the FDA’s go-ahead, Coya plans to launch a multicenter phase 2 trial of COYA 302 in patients with ALS, CEO Arun ...
The Food and Drug Administration has issued warning letters to several companies producing whipped formulas of sunscreen.
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...
FDA delays Axogen's Avance Nerve Graft BLA review to December 5, after new data submission, while the company raises its full ...
Although VIZZ is, so far, the first and only FDA-approved aceclidine eye drop, it’s one of three prescription eye drops ...
A. The Food and Drug Administration has approved montelukast to treat asthma, exercise-induced bronchoconstriction (trouble ...
The U.S. Food and Drug Administration has started "real-time reporting of adverse event data," according to an annoucement ...
On Tuesday, the Food and Drug Administration (FDA) warned consumers about potential contamination of a well-known brand of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results